Neuroendocrine Tumours

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2018-01-26
FDA Approved: LUTATHERA — Original Application (Advanced Accelerator Applications USA, Inc)
The FDA approved LUTATHERA (Lutetium-177 dotatate) from Advanced Accelerator Applications USA, Inc., for adults with somatostatin receptor–p…